發送短信 : Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

  _____      ___      _____      ___     _    _   
 |__  //    / _ \\   /  ___||   / _ \\  | |  | || 
   / //    | / \ || | // __    | / \ || | |/\| || 
  / //__   | \_/ || | \\_\ ||  | \_/ || |  /\  || 
 /_____||   \___//   \____//    \___//  |_// \_|| 
 `-----`    `---`     `---`     `---`   `-`   `-`